Litigation Details for CHRISTENSEN v. NOVO NORDISK INC. (D.N.J. 2017)
✉ Email this page to a colleague
CHRISTENSEN v. NOVO NORDISK INC. (D.N.J. 2017)
Docket | ⤷ Try a Trial | Date Filed | 2017-04-19 |
Court | District Court, D. New Jersey | Date Terminated | 2018-01-18 |
Cause | 15:15 Antitrust Litigation | Assigned To | Brian R. Martinotti |
Jury Demand | Plaintiff | Referred To | Lois H. Goodman |
Parties | EMMA JENSEN | ||
Patents | 7,476,652; 7,713,930; 7,918,833; 8,512,297; 8,556,864; 8,603,044; 8,679,069 | ||
Attorneys | ELLEN RELKIN | ||
Firms | Weitz & Luxenberg Pc | ||
Link to Docket | External link to docket |
Biologic Drugs cited in CHRISTENSEN v. NOVO NORDISK INC.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for CHRISTENSEN v. NOVO NORDISK INC. (D.N.J. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-05-15 | 9 | 13, 2009, the PTO issued U.S. Patent No. 7,476,652 (“the ’652 patent”), entitled “Acidic Insulin Preparations… 165. The ’833 patent, the ’297 patent, the ’864 patent and the ’044 patent are herein called …ingredient) patents, drug product (formulation and composition) patents, and method of use patents.”10 The… In the ’930 patent, which has the same examples as the ’652 patent, a different patent examiner allowed…polysorbate vial formulation patents, Sanofi listed the ’652 patent and the ’930 patent to be identified in | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |